TITLE

Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma

AUTHOR(S)
Lida, H.; Honda, M.; Kawai, H. F.; Yamashita, T.; Shirota, Y.; Wang, B.-C.; Miao, H.; Koneko, S.
PUB. DATE
June 2005
SOURCE
Gut;Jun2005, Vol. 54 Issue 6, p843
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: α-Fetoprotein (AFP), a tumour marker for hepatocellular carcinoma (HCC), is associated with poor prognosis. Using cDNA microarray analysis, we previously found that ephrin-A1, an angiogenic factor, is the most differentially overexpressed gene in AFP producing hepatoma cell lines. In the present study, we investigated the significance of ephrin-A1 expression in HCC. Methods: We examined ephrin-A1 expression and its effect on cell proliferation and gene expression in five AFP producing hepotoma cell lines, three AFP negative hepatoma cell lines, and 20 human HCC specimens. Results: Ephrin-A1 expression levels were lowest in normal liver tissue, elevated in cirrhotic tissue, and further elevated in HCC specimens. Ephrin-A1 expression was strongly correlated with AFP expression (r=0.866). We showed that ephrin-A1 induced expression of AFP. This finding implicates ephrin-A1 in the mechanism of AFP induction in HCC. Ephrin-A1 promoted the proliferation of ephrin-A1 underexpressing HLE cells, and an ephrin-A1 antisense oligonucleotide inhibited the proliferation of ephrin-A1 overexpressing Huh7 cells. Thus ephrin-M affects hepatoma cell growth. cDNA microarray analysis showed that ephrin-A1 induced expression of genes related to the cell cycle (p21), angiogenesis (angiopoietin 1 and thrombospondin 1), and cell-cell interactions (Rho, integrin, and matrix metalloproteinases) in cultured hepatoma cells. These ephrin-A1 induced genes are also activated in HCC tissues that overexpress AFP. Conclusion: These findings suggest that the poor prognosis of patients with AFP producing HCC is partially caused by ephrin-A1 expression, which induces expression of genes related to tumour cell growth, angiogenesis, invasion, and metastasis.
ACCESSION #
17176787

 

Related Articles

  • Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways. Lizao Chen; Jianming Zheng; Yan Zhang; Luxi Yang; Jiaqi Wang; Jian Ni; Daxiang Cui; Chaoqin Yu; Zailong Cai // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1521 

    MicroRNA-26a (miR-26a) is a tumor suppressor that is reduced in hepatocellular carcinoma (HCC). Increasing evidence indicates that the liver is a hormone-responsive organ like the breast. The purpose of this study was to investigate whether miR-26a, regulated by a human α-fetoprotein (hAFP)...

  • Overexpression of caspase-3 in hepatocellular carcinomas. Persad, Rajendra; Liu, Chen; Wu, Tsung-Teh; Houlihan, Patrick S.; Hamilton, Stanley R.; Diehl, Anna M.; Rashid, Asif // Modern Pathology;Jul2004, Vol. 17 Issue 7, p861 

    Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in...

  • Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma. Tovuu, Lkhagva-Ochir; Imura, Satoru; Utsunomiya, Tohru; Morine, Yuji; Ikemoto, Tetsuya; Arakawa, Yusuke; Mori, Hiroki; Hanaoka, Jun; Kanamoto, Mami; Sugimoto, Koji; Iwahashi, Shuichi; Saito, Yu; Yamada, Shinichiro; Asanoma, Michihito; Miyake, Hidenori; Shimada, Mitsuo // International Journal of Clinical Oncology;Aug2013, Vol. 18 Issue 4, p651 

    Background: CD44 is well known to be one of the cancer stem cell markers and is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion, and cell migration. We investigated the role of CD44 expression in both tumor and non-tumor tissues on recurrence of hepatocellular...

  • Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model. Li-cheng Dai; Xiang Wang; Xing Yao; Li-shan Min; Jin-liang Ping; Jian-fang He // Acta Pharmacologica Sinica;Mar2007, Vol. 28 Issue 3, p453 

    Aim: To evaluate the in vivo antitumor effects of antisense oligonucleotides targeting midkine (MK-AS). Methods: An in situ human hepatocellular carcinoma (HCC) model was established in mice livers orthotopically. The MK-AS and 5-fluorouracil (5-Fu) were administered intravenously. The tumor...

  • α-Fetoprotein and β-Human Chorionic Gonadotropin: Their Clinical Significance as Tumour Markers. Gregory, J.J.J.; Finlay, J.L. // Drugs;Apr1999, Vol. 57 Issue 4, p463 

    Tumour markers can aid in areas such as diagnosis, surveillance of recurrence, staging and prognosis. This article focuses on 2 tumour markers, α-fetoprotein (AFP) and β-human chorionic gonadotropin (HCG). These tumour markers have been examined for their utility as prognostic indicators...

  • Fibrolamellar Carcinoma of the Liver With a Mixture of Ordinary Hepatocellular Carcinoma: A Case Report. Okano, Akihiro; Hajiro, Kiyoshi; Takakuwa, Hiroshi; Kobashi, Yoichiro // American Journal of Gastroenterology;Jul1998, Vol. 93 Issue 7, p1144 

    Fibrolamellar carcinoma (FLC) of the liver is a rare variant of hepatocellular carcinoma (HCC), and only 13 cases have been reported in Japan up to 1997. We described a histologically unusual case of FLC. A 52-yr-old man was admitted to our hospital for work-up of hepatic mass. Laboratory...

  • Perspectives on a combined test of multi serum biomarkers in China: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Keming Zhang; Peipei Song; Jianjun Gao; Gaohua Li; Xin Zhao; Shaogeng Zhang // Drug Discoveries & Therapeutics;Jun2014, Vol. 8 Issue 3, p102 

    China has 50% of the worldwide hepatocellular carcinoma (HCC) cases, and the HBV-related cases accounts for approximately 85%. Over the past few decades, although a series of standardized management methods for HCC has been implemented in China, most HCC patient in China still suffered from...

  • Immunohistochemical and Affinity Electrophoretic Studies of α-Fetoprotein of a Patient with Hepatocellular Carcinoma in the Intrathoracic Space. Moriwaki, Yuji; Higashino, Kazuya; Taketa, Kazuhisa; Hada, Toshikazu; Tamura, Shinsuke; Yamaguchi, Kei // American Journal of Gastroenterology;Nov1987, Vol. 82 Issue 11, p1207 

    Immunohistochemical and affinity electrophoretic studies were carried out on α-fetoprotein components produced by a tumor of hepatocellular origin located on the chest wall and originating from the intrathoracic and extrapleural space tissue. The major components of α-fetoprotein were...

  • Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C. Sterling, Richard K; Wright, Elizabeth C; Morgan, Timothy R; Seeff, Leonard B; Hoefs, John C; Di Bisceglie, Adrian M; Dienstag, Jules L; Lok, Anna S // American Journal of Gastroenterology;Jan2012, Vol. 107 Issue 1, p64 

    OBJECTIVES:Prospective studies of serum hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C are lacking. The aim of this study was to determine the frequencies and performance of elevated α-fetoprotein (AFP), AFP-L3, and des-γ-carboxy prothrombin (DCP) levels as...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics